Catalyst Pharmaceuticals Inc (CPRX)
Days of sales outstanding (DSO)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| DSO | days | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —
Based on the data provided, Catalyst Pharmaceuticals Inc's days of sales outstanding (DSO) are not available or provided for any of the specified dates ranging from March 31, 2020, to December 31, 2024.
DSO is a measure that indicates the average number of days a company takes to collect payment after making a sale. It is calculated by dividing accounts receivable by total credit sales and multiplying the result by the number of days in the period being analyzed.
A high DSO value may indicate that the company is facing challenges in collecting payments from customers, which can affect its cash flow and liquidity. In contrast, a low DSO value suggests that the company is efficient in collecting payments, leading to better cash flow management.
Without the specific DSO values for Catalyst Pharmaceuticals Inc, it is difficult to assess the company's efficiency in collecting receivables over time. It would be beneficial for stakeholders and investors to have access to these DSO figures to make more informed decisions regarding the company's financial performance and management of accounts receivable.
Peer comparison
Dec 31, 2024